Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer

NCT00006228 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

NIH

Sponsor class

Conditions

HER2-positive Breast Cancer
Male Breast Cancer
Recurrent Breast Cancer
Stage IV Breast Cancer

Interventions

BIOLOGICAL: trastuzumab
BIOLOGICAL: aldesleukin
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

National Cancer Institute (NCI)